http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016245821-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1852a765b638c68f881cc5cac2746ba7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2219-00725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2219-00596
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J19-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16C20-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-65
filingDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa67b7fffaf4bd6139c59d719698f7ec
publicationDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016245821-A1
titleOfInvention Method of developing small molecule peptide conjugates for biomedical applications
abstract This application provides a platform design wherein a substrate peptide of the protein-protein interaction complex is tagged with a variety of small molecule fragments using amide chemistry. The method of hit discovery coupled with subsequent amide-mediated rapid diversification for lead generation reduces time and cost to discovery and development of target specific small molecule leads for the inhibition of protein-protein interactions.
priorityDate 2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004235027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003032782-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013053541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040423-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227862176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18634656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548

Total number of triples: 40.